| The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases F Ozkalemkas, R Ali, V Ozkocaman, T Ozcelik, U Ozan, H Ozturk, E Kurt, ... BMC cancer 5, 1-9, 2005 | 165 | 2005 |
| Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes V Ozkocaman, T Ozcelik, R Ali, F Ozkalemkas, A Ozkan, C Ozakin, ... Journal of Hospital Infection 64 (2), 169-176, 2006 | 128 | 2006 |
| Imatinib use during pregnancy and breast feeding: a case report and review of the literature R Ali, F Ozkalemkas, Y Kimya, N Koksal, V Ozkocaman, T Gulten, ... Archives of gynecology and obstetrics 280, 169-175, 2009 | 89 | 2009 |
| Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of … R Ali, F Özkalemkas, V Özkocaman, T Özçelik, Ü Ozan, Y Kimya, A Tunali Japanese Journal of Clinical Oncology 34 (4), 215-217, 2004 | 89 | 2004 |
| Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience H Bekoz, M Ozbalak, N Karadurmus, S Paydas, A Turker, T Toptas, ... Annals of Hematology 99, 2565-2576, 2020 | 80 | 2020 |
| Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML): Outcome of discontinuation of imatinib therapy after achieving … R Ali, F Özkalemkaş, T Özçelik, V Özkocaman, Ü Ozan, Y Kimya, N Köksal, ... Leukemia research 29 (8), 971-973, 2005 | 69 | 2005 |
| Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years R Ali, F Özkalemkaş, T Özçelik, V Özkocaman, Ü Ozan, Y Kimya, A Tunalı Leukemia research 27 (5), 381-385, 2003 | 62 | 2003 |
| Neonatal outcomes of pregnancy complicated by idiopathic thrombocytopenic purpura H Özkan, M Cetinkaya, N Köksal, R Ali, AM Güneş, B Baytan, ... Journal of Perinatology 30 (1), 38-44, 2010 | 55 | 2010 |
| Pesg PNH diagnosis, follow-up and treatment guidelines F Sahin, OM Akay, M Ayer, MS Dal, S Ertop, O Ilhan, V Karakus, ... American Journal of Blood Research 6 (2), 19, 2016 | 53 | 2016 |
| Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes R Ali, F Özkalemkaş, T Özçelik, V Özkocaman, Ü Ozan, Y Kimya, N Köksal, ... Annals of hematology 82, 348-352, 2003 | 51 | 2003 |
| Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey A Salihoglu, T Elverdi, I Karadogan, S Paydas, E Ozdemir, G Erdem, ... Annals of hematology 94, 415-420, 2015 | 46 | 2015 |
| 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy E Alper, M Gurel, T Evrensel, V Ozkocaman, T Akbunar, M Demiray Nuclear medicine communications 24 (5), 537-542, 2003 | 38 | 2003 |
| Tuberculosis presenting as immune thrombocytopenic purpura F Ozkalemkas, R Ali, A Ozkan, T Ozcelik, V Ozkocaman, E Kunt-Uzaslan, ... Annals of Clinical Microbiology and Antimicrobials 3, 1-5, 2004 | 36 | 2004 |
| Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis R Ali, F Özkalemkaş, V Özkocaman, E Bülbül-Başkan, T Özçelik, Ü Ozan, ... Annals of hematology 83, 61-63, 2004 | 36 | 2004 |
| Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia R Ali, F Ozkalemkas, T Ozcelik, V Ozkocaman, A Ozkan, S Bayram, ... Annals of Clinical Microbiology and Antimicrobials 5, 1-6, 2006 | 28 | 2006 |
| Fatal breakthrough infection with Fusarium andiyazi: new multi‐resistant aetiological agent cross‐reacting with Aspergillus galactomannan enzyme immunoassay N Kebabcı, AD van Diepeningen, B Ener, T Ersal, M Meijer, ... Mycoses 57 (4), 249-255, 2014 | 27 | 2014 |
| Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera M Karkucak, T Yakut, V Ozkocaman, F Ozkalemkas, R Ali, M Bayram, ... Molecular biology reports 39, 8663-8667, 2012 | 27 | 2012 |
| Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy A Ozkan, B Hakyemez, F Ozkalemkas, R Ali, V Ozkocaman, T Ozcelik, ... Neuroradiology 48, 887-892, 2006 | 27 | 2006 |
| Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon R Ali Leuk Res. 31, 1153-1155, 2007 | 25 | 2007 |
| Second primary cancer due to radiotherapy and chemotherapy. O Manavoğlu, B Orhan, T Evrensel, Y Karabulut, V Ozkocaman, ... Journal of environmental pathology, toxicology and oncology: official organ …, 1996 | 25 | 1996 |
